Oculis Holding AG (OCS) Assets Average (2023 - 2026)

Oculis Holding AG's (OCS) quarterly Assets Average came in at $303.4 million in Q1 2026, up 66.49% year-on-year from $182.2 million in Q1 2025, and up 20.15% quarter-over-quarter from $252.5 million in Q4 2025.

Oculis Holding AG (OCS) Assets Average (2023 - 2026) Analysis & Trends

Oculis Holding AG's Assets Average history runs 4 years deep, the most recent figure standing at $303.4 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 66.49% year-over-year to $303.4 million in Q1 2026; TTM through Mar 2026 was $303.4 million, a 66.49% increase from a year earlier, with the FY2025 full-year figure at $210.7 million, up 59.54% from the prior year.
  • Assets Average advanced to $303.4 million in Q1 2026 per OCS's latest filing, from $252.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $303.4 million in Q1 2026 and bottomed at $121.0 million in Q1 2024.
  • The 4-year median for Assets Average is $149.2 million (2024), against an average of $182.4 million.
  • Across the five-year window, Assets Average increased 0.82% in 2024 and jumped 78.86% in 2025, its largest moves.
  • Year by year, Assets Average stood at $137.4 million in 2023, then advanced by 2.72% to $141.2 million in 2024, then soared by 78.86% to $252.5 million in 2025, then climbed by 20.15% to $303.4 million in 2026.
  • Per Business Quant, the three latest OCS Assets Average figures stand at $303.4 million (Q1 2026), $252.5 million (Q4 2025), and $214.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 303.40 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 65.01 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 40.89 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 8.37 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 795.91 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 2.30 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 5.05 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 303.40 Mn
Dec 31, 2025 252.52 Mn
Sep 30, 2025 214.60 Mn
Jun 30, 2025 223.23 Mn
Mar 31, 2025 182.24 Mn
Dec 31, 2024 141.18 Mn
Sep 30, 2024 149.19 Mn
Jun 30, 2024 133.25 Mn
Mar 31, 2024 121.01 Mn
Dec 31, 2023 137.45 Mn
Sep 30, 2023 147.98 Mn